Can omeprazole reduce ketoconazole absorption in horses?

The Omepratex horse product information says that omeprazole may decrease absorption of medicines requiring a lower gastric pH for optimal absorption, and names ketoconazole. The warning is about absorption; it is not evidence that every treated horse will have treatment failure. [1]

Mechanism and evidence interpretation

Reduced absorption at higher gastric pH. This is an official-label absorption warning for horses. It does not quantify ketoconazole exposure for a particular formulation, dose, route or patient. [1]

Omeprazole may decrease absorption of drugs requiring decreased gastric pH for optimal absorption (ketoconazole, itraconazole, iron, ampicillin esters). [1] [2] [3] [4] [5]

The quotation is the recorded official-label wording. It may mention other medicines; only the pair in this article’s title is discussed here.

Does separating administration times solve the interaction?

These are questions for veterinary review, not instructions to start, stop or change a medicine.

Which animals and evidence types does this cover?

The selected catalogue scope is horses. A product-label statement is not automatically a controlled interaction trial. It does not establish an effect size, incidence, dose adjustment or applicability to another species.

Does a horse product label establish an interaction in every animal species?

No. This page concerns a statement in horse product information. It should not be silently transferred to dogs, reptiles or another target species, and it does not replace formulation-specific evidence.

No matching rule does not establish safety. FDA adverse-event reports alone cannot prove an interaction or its incidence.

Catalogue review status and limitations

The matched catalogue records are marked verified and direct. This is a catalogue review status; it does not mean every patient-specific conclusion has been clinically demonstrated.

Catalogue review status
verified
Inference status
direct
Stored interaction role
risk_interaction
Catalogue severity
moderate

These fields are shown separately. They are not a claim of independent expert consensus or a patient-specific recommendation.

Evidence sources

This page draws on 5 catalogue record(s) and 5 distinct source entries. These are not independent clinical studies; repeated product labels may carry the same warning.

The summary was checked against the linked primary VMD PDF on 16 November 2026. Source URLs can change; the catalogue citations retain recorded version identifiers.

  1. Official product information

    VMD PID:A013451, Omepratex 370 mg/g Oral Paste for Horses, version 56370555dd50ca2a78ee2c233a718461 Open official source

  2. Official product information

    VMD PID:A013447, Gastazole 370 mg/g Oral Paste for Horses, version 0c18ac813e85d4901fb997157f704639 Open official source

  3. Official product information

    VMD PID:A013453, EU Pharma Omeprazole 370 mg/g Oral Paste for Horses, version c4f2ebc90fd20707cbc626a9c3e8c807 Open official source

  4. Official product information

    VMD PID:A013448, Omeprogard 370 mg/g Oral Paste for Horses, version 9b56cd113769235b96635e4c6f927ce3 Open official source

  5. Official product information

    VMD PID:A013450, Omepratex 370 mg/g Oral Paste for Horses, version b75d97ecabe87f85976f33d55b6d6078 Open official source

Content responsibility: ZooDDI. This is a source-linked reference for veterinary review, not a diagnosis, prescription or emergency service. No independent clinical reviewer is claimed.

Check a complete medication regimen